Table:
begin	end	state
1	8	cytoplasmic
9	35	transmembrane
36	50	non-cytoplasmic
51	71	transmembrane
72	77	cytoplasmic
78	104	transmembrane
105	106	non-cytoplasmic
107	126	transmembrane
127	137	cytoplasmic
138	159	transmembrane
160	169	non-cytoplasmic
170	192	transmembrane
193	211	cytoplasmic
212	234	transmembrane
235	239	non-cytoplasmic
240	256	transmembrane
257	270	cytoplasmic
271	293	transmembrane
294	312	non-cytoplasmic
313	343	transmembrane
344	354	cytoplasmic
355	378	transmembrane
379	398	non-cytoplasmic
399	424	transmembrane
425	427	cytoplasmic

Input:
>AZOBR_RS26625 FitnessBrowser__azobra:AZOBR_RS26625
VTIVIFVGSLLGAMALGLPIAFALIVSGLALMAFMGMLDPQIVVQSMWDGANSFPLLAVP
FFMLAGEFMNAGGMSRRIIAMAMAWVGHLRGGLGFVAVFAAILMASLSGSAVADTAALAS
ILLPMMRQAGYDIHRSGGLIAAGGIIAPVIPPSIGMILYGVAGQVSITKLFLAGIVPGIM
MGVALLITWWWLARREILTTPPKVPLRERLRLTADAFWAMLLPVVIIGGLKTGVFTPTEA
AVVAAVYAMFVGLVIYRELRIADLYGLMLSAAKTTAVVMFLVAAAGISAWLITASNIPAQ
LADLLAPVMDNRLLLMLALMVIVLIVGTALDFAPTILLMVPVLMPIIKQAGIDPVYFGVL
FIMNNAIGLITPPVGTVLNVVCGVGRMSMSNLMKGVGPFLLAQTAVLFLLVLFPELVMAP
LAWFTAR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server